Total Payments
$1,869
2024 Payments
$284.28
Companies
18
Transactions
115
Medicare Patients
10,315
Medicare Billing
$498,944
Payment Breakdown by Category
Food & Beverage$1,869 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,869 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $440.62 | 29 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $273.59 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $257.39 | 20 | $0 (2020) |
| PFIZER INC. | $164.92 | 8 | $0 (2024) |
| Abbott Laboratories | $93.94 | 3 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $93.34 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $86.22 | 6 | $0 (2018) |
| Amgen Inc. | $74.74 | 5 | $0 (2019) |
| Medtronic, Inc. | $65.01 | 3 | $0 (2023) |
| Medtronic Vascular, Inc. | $63.76 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $284.28 | 13 | Impulse Dynamics (USA) Inc. ($93.34) |
| 2023 | $238.86 | 10 | Novartis Pharmaceuticals Corporation ($88.77) |
| 2022 | $114.41 | 7 | Novartis Pharmaceuticals Corporation ($63.52) |
| 2021 | $117.30 | 8 | Novartis Pharmaceuticals Corporation ($83.21) |
| 2020 | $66.64 | 5 | E.R. Squibb & Sons, L.L.C. ($28.05) |
| 2019 | $575.34 | 39 | Janssen Pharmaceuticals, Inc ($146.18) |
| 2018 | $210.61 | 15 | Novartis Pharmaceuticals Corporation ($53.55) |
| 2017 | $261.36 | 18 | Janssen Pharmaceuticals, Inc ($58.24) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $27.59 | General |
| Category: Cardiovascular Device | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: Cardiovascular | ||||||
| 07/17/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $65.75 | General |
| Category: Cardiovascular Device | ||||||
| 06/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Cardiovascular | ||||||
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Cardiovascular | ||||||
| 02/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/05/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/03/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $50.42 | General |
| Category: Heart Failure | ||||||
| 06/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/12/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $50.16 | General |
| Category: CONTRAST AGENT | ||||||
| 04/16/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Transcatheter Valve Systems | ||||||
| 03/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,171 | 2,664 | $338,266 | $122,254 |
| 2022 | 25 | 2,437 | 2,879 | $366,872 | $131,167 |
| 2021 | 22 | 2,887 | 3,393 | $358,725 | $133,777 |
| 2020 | 28 | 2,820 | 3,220 | $322,822 | $111,745 |
Total Patients
10,315
Total Services
12,156
Medicare Billing
$498,944
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 451 | 721 | $147,805 | $60,389 | 40.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 293 | 296 | $48,840 | $14,595 | 29.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 101 | $39,693 | $12,958 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 155 | $21,855 | $9,122 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 63 | $12,789 | $5,706 | 44.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 493 | 594 | $11,860 | $3,228 | 27.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $6,360 | $2,249 | 35.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 74 | 74 | $6,354 | $1,942 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 36 | $4,968 | $1,908 | 38.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 22 | 22 | $6,072 | $1,798 | 29.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 73 | 77 | $6,160 | $1,405 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,454 | $1,130 | 32.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 13 | 13 | $2,873 | $823.16 | 28.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 14 | 14 | $2,576 | $738.22 | 28.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 29 | 30 | $1,632 | $522.29 | 32.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 57 | $3,021 | $517.92 | 17.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 13 | $1,016 | $449.88 | 44.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 79 | 84 | $1,764 | $439.83 | 24.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 27 | 27 | $1,701 | $407.25 | 23.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 12 | 12 | $1,002 | $340.56 | 34.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 32 | 33 | $1,914 | $311.52 | 16.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 29 | 29 | $1,218 | $311.46 | 25.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 92 | 97 | $970.00 | $224.66 | 23.2% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 13 | 13 | $832.00 | $214.80 | 25.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 23 | $208.00 | $193.20 | 92.9% |
About Dr. Susan Schima, M.D
Dr. Susan Schima, M.D is a Internal Medicine healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871674341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Schima, M.D has received a total of $1,869 in payments from pharmaceutical and medical device companies, with $284.28 received in 2024. These payments were reported across 115 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,869).
As a Medicare-enrolled provider, Schima has provided services to 10,315 Medicare beneficiaries, totaling 12,156 services with total Medicare billing of $498,944. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Cedar Rapids, IA
- Active Since 10/18/2006
- Last Updated 08/20/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871674341
Products in Payments
- ENTRESTO (Drug) $372.92
- ELIQUIS (Drug) $280.27
- XARELTO (Drug) $257.39
- Optimizer (Device) $93.34
- CoreValve Evolut (Device) $86.61
- PRADAXA (Drug) $86.22
- CAMZYOS (Drug) $85.05
- Corlanor (Drug) $74.74
- VYNDAQEL (Drug) $73.19
- LEQVIO (Drug) $67.70
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $50.42
- DEFINITY (Drug) $50.16
- COREVALVE EVOLUT R (Device) $42.16
- BRILINTA (Drug) $35.64
- PRALUENT (Drug) $34.71
- LifeVest (Device) $34.44
- PRALUENT (Biological) $25.68
- Supera peripheral stent system (Device) $24.92
- JOT DX (Device) $18.60
- BYSTOLIC (Drug) $17.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cedar Rapids
Dr. Stanley Mathew, M.d, M.D
Internal Medicine — Payments: $13,615
Internal Medicine $13,615
Dr. Bharat Jenigiri, Md, MD
Internal Medicine — Payments: $8,089
Internal Medicine $8,089
Fadi Yacoub, Md, MD
Internal Medicine — Payments: $7,348
Internal Medicine $7,348
Rezwan Munshi, Md, MD
Internal Medicine — Payments: $2,116
Internal Medicine $2,116
Dr. Amandeep Singh Dhaliwal, M.d, M.D
Internal Medicine — Payments: $2,006
Internal Medicine $2,006
Dr. Fahed Al Darazi, Md, MD
Internal Medicine — Payments: $1,279
Internal Medicine $1,279